Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
IONS
IONS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IONS News
Executive Departure: Eugene Schneider Leaves Role
Jun 30 2026
Yahoo Finance
Biotech Sector Update: FDA and EU Approvals
Jun 26 2026
NASDAQ.COM
Ionis Secures FDA Approval for Tryngolza and Signs Recordati Licensing Deal for Zilganersen
Jun 25 2026
Newsfilter
Ionis Enters License Agreement with Recordati for Zilganersen
Jun 25 2026
NASDAQ.COM
Ionis Pharmaceuticals Receives FDA Approval for TRYNGOLZA
Jun 25 2026
NASDAQ.COM
Ionis Pharmaceuticals Enters License Agreement with Recordati for Zilganersen
Jun 25 2026
seekingalpha
Ionis and Recordati Enter Exclusive License Agreement for Zilganersen
Jun 25 2026
Newsfilter
FDA Approves Tryngolza for Severe Hypertriglyceridemia Treatment
Jun 25 2026
stocktwits
FDA Approves New Indication for Ionis' Tryngolza
Jun 24 2026
seekingalpha
Ionis Receives FDA Approval for TRYNGOLZA
Jun 24 2026
Newsfilter
Ionis Pharmaceuticals Appoints New Board Member
Jun 08 2026
NASDAQ.COM
Ionis Pharmaceuticals Appoints Ludwig Hantson to Board of Directors
Jun 08 2026
Yahoo Finance
GSK's Antisense Drug Shows Promise in Hepatitis B Trials
May 28 2026
seekingalpha
Bepirovirsen Shows Significant Efficacy in Chronic Hepatitis B Trials
May 28 2026
Newsfilter
Citi Initiates Bullish Coverage on SMid Cap Biotechs
May 19 2026
seekingalpha
Biogen's Alzheimer Therapy Trial Shows Promising Results
May 14 2026
seekingalpha
Show More News
